146 related articles for article (PubMed ID: 21697888)
21. ALK and EGFR expression by immunohistochemistry are associated with Merkel cell polyomavirus status in Merkel cell carcinoma.
Veija T; Kero M; Koljonen V; Böhling T
Histopathology; 2019 May; 74(6):829-835. PubMed ID: 30588655
[TBL] [Abstract][Full Text] [Related]
22. Differentiating Merkel cell carcinoma of lymph nodes without a detectable primary skin tumor from other metastatic neuroendocrine carcinomas: The ELECTHIP criteria.
Kervarrec T; Zaragoza J; Gaboriaud P; Le Gouge A; Beby-Defaux A; Le Corre Y; Hainaut-Wierzbicka E; Aubin F; Bens G; Michenet P; Maillard H; Touzé A; Samimi M; Guyétant S
J Am Acad Dermatol; 2018 May; 78(5):964-972.e3. PubMed ID: 29180096
[TBL] [Abstract][Full Text] [Related]
23. CD99 and cytokeratin-20 in small-cell and basaloid tumors of the skin.
Nicholson SA; McDermott MB; Swanson PE; Wick MR
Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):37-41. PubMed ID: 10937047
[TBL] [Abstract][Full Text] [Related]
24. Merkel cell polyomavirus expression in merkel cell carcinomas and its absence in combined tumors and pulmonary neuroendocrine carcinomas.
Busam KJ; Jungbluth AA; Rekthman N; Coit D; Pulitzer M; Bini J; Arora R; Hanson NC; Tassello JA; Frosina D; Moore P; Chang Y
Am J Surg Pathol; 2009 Sep; 33(9):1378-85. PubMed ID: 19609205
[TBL] [Abstract][Full Text] [Related]
25. Dual inhibition of MDM2 and MDM4 in virus-positive Merkel cell carcinoma enhances the p53 response.
Park DE; Cheng J; Berrios C; Montero J; Cortés-Cros M; Ferretti S; Arora R; Tillgren ML; Gokhale PC; DeCaprio JA
Proc Natl Acad Sci U S A; 2019 Jan; 116(3):1027-1032. PubMed ID: 30598450
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Polo-like kinase 1 as a potential therapeutic target in Merkel cell carcinoma.
Kadletz L; Bigenzahn J; Thurnher D; Stanisz I; Erovic BM; Schneider S; Schmid R; Seemann R; Birner P; Heiduschka G
Head Neck; 2016 Apr; 38 Suppl 1():E1918-25. PubMed ID: 26713885
[TBL] [Abstract][Full Text] [Related]
27. KIT receptor (CD117) expression in Merkel cell carcinoma.
Strong S; Shalders K; Carr R; Snead DR
Br J Dermatol; 2004 Feb; 150(2):384-5. PubMed ID: 14996126
[No Abstract] [Full Text] [Related]
28. Merkel cell carcinoma: evaluation of KIT (CD117) expression and failure to demonstrate activating mutations in the C-KIT proto-oncogene - implications for treatment with imatinib mesylate.
Swick BL; Ravdel L; Fitzpatrick JE; Robinson WA
J Cutan Pathol; 2007 Apr; 34(4):324-9. PubMed ID: 17381803
[TBL] [Abstract][Full Text] [Related]
29. Aberrant expression of ALK and EZH2 in Merkel cell carcinoma.
Veija T; Koljonen V; Bohling T; Kero M; Knuutila S; Sarhadi VK
BMC Cancer; 2017 Mar; 17(1):236. PubMed ID: 28359267
[TBL] [Abstract][Full Text] [Related]
30. Activation of PI3K signaling in Merkel cell carcinoma.
Nardi V; Song Y; Santamaria-Barria JA; Cosper AK; Lam Q; Faber AC; Boland GM; Yeap BY; Bergethon K; Scialabba VL; Tsao H; Settleman J; Ryan DP; Borger DR; Bhan AK; Hoang MP; Iafrate AJ; Cusack JC; Engelman JA; Dias-Santagata D
Clin Cancer Res; 2012 Mar; 18(5):1227-36. PubMed ID: 22261808
[TBL] [Abstract][Full Text] [Related]
31. Expression of HuR in Merkel cell carcinoma and in normal skin.
Koljonen V; Böhling T; Haglund C; Ristimäki A
J Cutan Pathol; 2008 Jan; 35(1):10-4. PubMed ID: 18095988
[TBL] [Abstract][Full Text] [Related]
32. Bcl-2 expression indicates better prognosis of Merkel cell carcinoma regardless of the presence of Merkel cell polyomavirus.
Sahi H; Koljonen V; Kavola H; Haglund C; Tukiainen E; Sihto H; Böhling T
Virchows Arch; 2012 Nov; 461(5):553-9. PubMed ID: 22976527
[TBL] [Abstract][Full Text] [Related]
33. Expression of MUC 1 and Ep-CAM in Merkel cell carcinomas: implications for immunotherapy.
Kurzen H; Kaul S; Egner U; Deichmann M; Hartschuh W
Arch Dermatol Res; 2003 Aug; 295(4):146-54. PubMed ID: 12844224
[TBL] [Abstract][Full Text] [Related]
34. Neurofilament is superior to cytokeratin 20 in supporting cutaneous origin for neuroendocrine carcinoma.
Stanoszek LM; Chan MP; Palanisamy N; Carskadon S; Siddiqui J; Patel RM; Harms KL; Lowe L; Fullen DR; Harms PW
Histopathology; 2019 Feb; 74(3):504-513. PubMed ID: 30239030
[TBL] [Abstract][Full Text] [Related]
35. Merkel cell carcinoma: lack of KIT positivity and implications for the use of imatinib mesylate.
Yang Q; Hornick JL; Granter SR; Wang LC
Appl Immunohistochem Mol Morphol; 2009 Jul; 17(4):276-81. PubMed ID: 19276970
[TBL] [Abstract][Full Text] [Related]
36. Plasticity of neuropeptidergic neoplasm cells in the primary and metastatic Merkel cell carcinoma.
Godlewski J; Kowalczyk A; Kozielec Z; Pidsudko Z; Kmieć A; Siedlecka-Kroplewska K
Folia Histochem Cytobiol; 2013; 51(2):168-73. PubMed ID: 23907948
[TBL] [Abstract][Full Text] [Related]
37. Histogenesis of pure and combined Merkel cell carcinomas: An immunohistochemical study of 14 cases.
Narisawa Y; Koba S; Inoue T; Nagase K
J Dermatol; 2015 May; 42(5):445-52. PubMed ID: 25720654
[TBL] [Abstract][Full Text] [Related]
38. CD117, CK20, TTF-1, and DNA topoisomerase II-alpha antigen expression in small cell tumors.
Yang DT; Holden JA; Florell SR
J Cutan Pathol; 2004 Mar; 31(3):254-61. PubMed ID: 14984578
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of p27Kip1, p45Skp2 and Ki67 expression profiles in Merkel cell carcinoma, extracutaneous small cell carcinoma, and cutaneous squamous cell carcinoma.
Fernández-Figueras MT; Puig L; Musulen E; Gilaberte M; Ferrándiz C; Lerma E; Ariza A
Histopathology; 2005 Jun; 46(6):614-21. PubMed ID: 15910592
[TBL] [Abstract][Full Text] [Related]
40. Merkel cell carcinoma arising within a poroma: report of two cases.
Molina-Ruiz AM; Bernárdez C; Requena L; Rütten A
J Cutan Pathol; 2015 May; 42(5):353-60. PubMed ID: 25732727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
